Search site Search ticker symbol

Are you looking for a stock?

Try one of these

News Tagged By: Pharmaceuticals

Pfizer, AstraZeneca abandon talks for $100B merger: Report

Pfizer Inc., the world’s biggest drugmaker, held informal, now-discontinued talks with AstraZeneca Plc about possibly buying the London-based maker of asthma and heart drugs, according to two people...

Posted on 4-21-2014 at 9:30 AM
Tags: Pfizer, Pharmaceuticals

Pfizer beats sales and profit forecasts

Pfizer Inc reported better than expected fourth-quarter results, helped by higher sales of drugs for cancer, nerve pain and arthritis, and the company forecast 2014 earnings in line with Wall Street...

Posted on 1-28-2014 at 8:04 AM
Tags: Pfizer, Pharmaceuticals

Aggressive Valeant plans $1.5B share buyback

Valeant Pharmaceuticals International Inc.’s board has approved a new share buyback program for up to $1.5 billion.

Posted on 1-22-2014 at 9:09 AM
Tags: Valeant Pharmaceuticals, Pharmaceuticals

Valeant eyeing Pfizer’s generics unit: Report

Drug makers Valeant Pharmaceuticals International Inc., Actavis Plc and Mylan Inc. have all expressed interest in buying Pfizer Inc.’s (PFE-N) branded generics business, but no active discussions are...

Posted on 1-14-2014 at 7:32 AM
Tags: Pfizer, Valeant Pharmaceuticals, Pharmaceuticals

Forest Labs to buy Aptalis from TPG for $2.9B

Drug maker Forest Laboratories Inc. said it would buy specialty pharmaceutical maker Aptalis from private equity firm TPG Capital for $2.9 billion US in a deal it promised would increase next year’s...

Posted on 1-08-2014 at 2:27 PM
Tags: Pharmaceuticals

Sanofi MS drug suffers setback in key U.S. market

Sanofi's Lemtrada multiple sclerosis treatment has failed to win approval from U.S. regulators, dealing a setback to a drug that was at the heart of the French drugmaker's $20 billion US takeover of...

Posted on 12-30-2013 at 8:03 AM
Tags: Pharmaceuticals

Shoppers profit climbs but takeover costs weigh on bottom line

Shoppers Drug Mart Corp. posted a rise in third quarter net earnings and sales on strong growth in prescriptions filled and gains in the long-term care business but was also hit by costs associated...

Posted on 11-12-2013 at 9:10 AM
Tags: Shoppers Drug Mart, Loblaw, Pharmaceuticals, Retail

UK's Shire to pay $4.2B for rare disease firm ViroPharma

London-listed Shire is buying ViroPharma for $4.2 billion US, attracted by a pipeline of potentially lucrative drugs to treat rare diseases, a growing trend as drugs companies lose revenues from...

Posted on 11-11-2013 at 8:08 AM
Tags: Pharmaceuticals
Today's Guests
CTV.ca CTV Two CTV News CTV News Channel BNN - Business News Network CP24